Checking heart rhythm timing in women with premature ovarian insufficiency
Part of Heart & circulation, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study measures how quickly the heart “recharges” between beats (often shown as QT timing). It compares women with premature ovarian insufficiency to healthy women to understand whether ovarian insufficiency is linked to heart rhythm differences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 41 years old (or a healthy volunteer 18 to 40).
- If you have POI: you have missed periods (amenorrhea) and blood tests show high FSH (more than 25) on two checks a few weeks apart.
- If you have POI: do not be using hormone treatment that affects the brain–ovary hormone signals for at least 1 month before joining.
- You cannot be pregnant or breastfeeding.
- You should not take medicines known to lengthen QT or affect the heart’s electrical recovery time (including ongoing QT-affecting treatments).
- Avoid if you have a heart rhythm problem history, diabetes, or severe kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
This study tests whether a traditional Chinese herbal formula can improve ovarian function in women with premature ovarian insufficiency. The aim is to see if the herbal medicine helps by reducing cell damage and changing how genes are regulated.
This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.
This study tests whether a probiotic called Lactobacillus johnsonii can help women with premature ovarian insufficiency (early menopause). It aims to see if this probiotic is safe and can improve hormone levels or symptoms.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.